Kaushlendra Tripathi

Dr. Kaushlendra Tripathi


Biography

I am a dedicated Research Scientist and Educator with over a decade of experience driving cancer drug discovery from target identification to in vivo validation. My mission is to develop next-generation therapeutics for a broad spectrum of malignancies, including ovarian, breast, lung, and colon cancer, as well as hematologic cancers like Multiple Myeloma and AML. My expertise spans both small molecule inhibitors (focusing on PARP, DNMT, and STING pathways) and advanced biological therapies, including siRNA/mRNA drugs and CAR-T cell therapy. I am highly proficient in cutting-edge research methodologies, utilizing 3D organoid/spheroid and orthotopic models to accurately assess in vivo efficacy and drug combination studies. Current and Prior Research Focuses: Therapeutic Targets: Investigating the roles of oncogenes, the STING pathway, Smo (GPCR), and RAD6 in DNA repair, stem cell signaling, and acquired chemoresistance. Drug Delivery & Resistance: Studying the effect of exosome-mediated drug delivery and the mechanisms by which exosomes contribute to chemoresistance. Emerging Technologies: Utilizing circulating tumor DNA (ctDNA) as a liquid biopsy biomarker, and pioneering the development of RNA-based vaccines for both cancer and infectious diseases. Core Technical Skills: FACS, protein biochemistry, cell biology, and molecular biology.

Affiliations

No affiliation has been shared yet.

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.